Chester County News and Community Website
PHILADELPHIA, PA — EpiVario, Inc. has announced that the United States Patent and Trademark Office has granted them US Patent No. 12,077,527, while the Japan Patent Office has issued a …
EpiVario Secures Key Patents for Innovative Addiction Treatment Read More PHILADELPHIA, PA — EpiVario, Inc. has announced the addition of Chris Cashman as an independent director to its Board of Directors. Known for his extensive leadership in the pharmaceutical and …
EpiVario, Inc. Welcomes Chris Cashman to Board of Directors Read More PHILADELPHIA, PA — EpiVario has announced that its CEO, Thomas Kim, will participate in the prestigious Babson College Substance Use Disorder (SUD) Sprint program. Kim is among 30 innovators selected …
EpiVario CEO to Join Babson College’s Substance Use Disorder Sprint Program Read More PHILADELPHIA, PA — EpiVario, Inc. announced this week it has been awarded a $295,000 grant from the National Institute on Drug Abuse (NIDA). The grant aims to advance research on …
EpiVario Secures NIDA Grant to Tackle Cocaine Addiction Read More PHILADELPHIA, PA — EpiVario Inc., a biotechnology firm specializing in neuroepigenetics to treat addiction disorders, announced a significant licensing deal with ReEngage Therapeutics. The agreement involves several of EpiVario’s small …
EpiVario Licenses Cancer-Fighting Compounds in Strategic Move Read More